Yuji Teramura1, Hiroo Iwata. 1. Radioisotope Research Center, Kyoto University, Yoshida-Konoe-Cho, Sakyo-ku, Kyoto, Japan.
Abstract
BACKGROUND: Transplantation of pancreatic islets of Langerhans (islets) has been successfully used to treat insulin-dependent diabetes mellitus. However, it remains an experimental procedure, and some technical aspects should be improved. Among these issues, early graft loss induced by instant blood-mediated inflammatory reactions (IBMIR) is an urgent obstacle to overcome. Coating of islet surface with bioactive molecules has been studied as a method to inhibit IBMIR. METHODS: Poly(ethylene glycol) (PEG)-lipid or PEG-urokinase was immobilized onto islets through hydrophobic interaction and DNA hybridization. Efficacy of surface modification for the inhibition of IBMIR was evaluated using a syngenic mouse transplantation model. Outcomes evaluated were blood insulin levels immediately after transplantation, blood glucose levels, and histochemical analyses of transplanted islets within the liver. RESULTS: Insulin level sharply increased after transplantation in recipient mice with naive islets but remained low in recipients with surface-modified islets. A total of 250 naive islets or 125 modified islets were needed to normalize blood glucose levels of the diabetic mouse model. These results indicate that surface modification of islets effectively protects against IBMIR. CONCLUSION: Surface modification of islets with PEG-lipid or PEG-urokinase is a potential useful technology in the clinical application of islet transplantation.
BACKGROUND: Transplantation of pancreatic islets of Langerhans (islets) has been successfully used to treat insulin-dependent diabetes mellitus. However, it remains an experimental procedure, and some technical aspects should be improved. Among these issues, early graft loss induced by instant blood-mediated inflammatory reactions (IBMIR) is an urgent obstacle to overcome. Coating of islet surface with bioactive molecules has been studied as a method to inhibit IBMIR. METHODS:Poly(ethylene glycol) (PEG)-lipid or PEG-urokinase was immobilized onto islets through hydrophobic interaction and DNA hybridization. Efficacy of surface modification for the inhibition of IBMIR was evaluated using a syngenic mouse transplantation model. Outcomes evaluated were blood insulin levels immediately after transplantation, blood glucose levels, and histochemical analyses of transplanted islets within the liver. RESULTS: Insulin level sharply increased after transplantation in recipient mice with naive islets but remained low in recipients with surface-modified islets. A total of 250 naive islets or 125 modified islets were needed to normalize blood glucose levels of the diabeticmouse model. These results indicate that surface modification of islets effectively protects against IBMIR. CONCLUSION: Surface modification of islets with PEG-lipid or PEG-urokinase is a potential useful technology in the clinical application of islet transplantation.
Authors: Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski Journal: Transplantation Date: 2016-02 Impact factor: 4.939
Authors: Alexander U Ernst; Daniel T Bowers; Long-Hai Wang; Kaavian Shariati; Mitchell D Plesser; Natalie K Brown; Tigran Mehrabyan; Minglin Ma Journal: Adv Drug Deliv Rev Date: 2019-02-02 Impact factor: 15.470